Citius Oncology, Inc. (CTOR) — Capital Reinvestment Ratio
Citius Oncology, Inc. (CTOR) has a Capital Reinvestment Ratio of 0.00x as of September 2024, meaning it reinvests 0% of its operating cash flow ($900.29K) in capital expenditures ($0.46). Check Citius Oncology, Inc. tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Citius Oncology, Inc. Capital Reinvestment Ratio (2024–2024)
This chart tracks Citius Oncology, Inc.'s Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see Citius Oncology, Inc. cash conversion from operations.
Annual Capital Reinvestment Ratio for Citius Oncology, Inc. (2024–2024)
Year-by-year Capital Reinvestment Ratio for Citius Oncology, Inc. from 2024 to 2024. See Citius Oncology, Inc. free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.00x | $126.35K | $4.00 | — |